STZ is generally used to induce type 1 diabetes mellitus by intraperitoneal or intravenous injection at a dose of 45 to 65 mg/kg depending on the route of administration.
It seems that nicotinamide combined with STZ induces type 2 diabetes mellitus. If possible, I would like someone to enlighten me on this induction mechanism.